Abstract
Background
Absolute neutrophil count (ANC) below 1.5 G/l or 1 G/l is commonly used as a factor to determine the decision to administer antineoplastic treatment including chemotherapy and novel agents to cancer patients. This practice is based on observations that below this ANC, there is an increased risk of bacterial and fungal infection. This is further based on the assumption that this parameter always correctly reflects the true shortage of these germ-fighting cells in patients. In reality, the circulating pool of neutrophils is only one of four reservoirs (bone marrow, circulating, marginal and tissue pools) and its size is influenced not only by shortage but also by transient shift of cells between these reservoirs. The aim of this study was to evaluate whether repeated blood collection affects ANC in the patient.
Methods
We retrospectively analysed the medical records of cancer patients with 0.8 G/l ≤ ANC < 1.5 G/l in whom CBC was repeated based on the physician’s decision, which was done on the same day roughly 2 h after the first one.
Results
The patients at the time of repeating CBC had consumed breakfast. In 31 out of 32 patients, ANC exceeded 1 G/l or 1.5 G/l and antineoplastic treatment was administered as originally planned. There were no infectious complications observed.
Conclusion
Cancer patients should not be fasting prior to blood collection, with the exception of special and rare situations. To achieve the maximum clinical benefit, delays and/or reductions of antineoplastic treatment should be avoided wherever possible. Pseudoneutropenia is an unnecessary reason for postponing chemotherapy.
Similar content being viewed by others
Change history
30 November 2020
The correct unit in all instances should be G/l instead of g/l.
References
Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–340
Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C (1995) Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 332:901–906
Bosly A, Bron D, Van Hoof A, De Bock R, Berneman Z, Ferrant A, Kaufman L, Dauwe M, Verhoef G (2008) Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Ann Hematol 87:277–283
Brandenberger G, Follenius M, Hietter B (1982) Feedback from meal-related peaks determines diurnal changes in cortisol response to exercise. J Clin Endocrinol Metab 54:592–596
Chirivella I, Bermejo B, Insa A, Perez-Fidalgo A, Magro A, Rosello S, Garcia-Garre E, Martin P, Bosch A, Lluch A (2009) Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients. Breast Cancer Res Treat 114:479–484
Drenick EJ, Alvarez LC (1971) Neutropenia in prolonged fasting. Am J Clin Nutr 24:859–863
Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study G (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83:1345–1350
Jedrzejczak WW (1975) Assessment of the value of prednisone test in differential diagnosis of neutropenic state. Blut 31:69–76
Jedrzejczak WW, Sulek K, Siekierzynski M (1979) Mobilization of the marginal pool of neutrophils with epinephrine. Results in healthy persons, patients with neutropenias, patients with neutrophilias, and patients with changes in neutrophil count induced by cancer chemotherapy. Haematologica 64:586–596
Kruszewski J, Szyszkowski A, Jedrzejczak WW (1981) Adrenaline test: its practical application. Wiad Lek 34:1669–1673
Slag MF, Ahmad M, Gannon MC, Nuttall FQ (1981) Meal stimulation of cortisol secretion: a protein induced effect. Metabolism 30:1104–1108
Zhang S, Chen Q, Wang Q (2016) The use of and adherence to CTCAE v3.0 in cancer clinical trial publications. Oncotarget 7:65577–65588
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Waszczuk-Gajda, A., Kraj, L., Woźniak, K. et al. Pseudoneutropenia as a factor-limiting access to chemotherapy for cancer patients: the effect of a simple meal. Support Care Cancer 29, 3767–3771 (2021). https://doi.org/10.1007/s00520-020-05896-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05896-x